What I've been told (by an Israeli analyst who attended the meeting) Eyal Desheh said is they don't manufacture enoxaparin in-house but have a partner.
MNTA - Question about tax assets. Per the last 10k MNTA claimed about 250M of operating loss carryforward and total deferred tax assets of $115M (including $92M of state and federal net operating losses).
Simple question - how many quarters of, say, $65M per quarter of operating income (before taxes) before they use up their tax assets? (I assume it is just ($250-$32M (Net income this q))/$65M= about 3.5 more quarters before it is used up.
PS I assume that the deferred tax asset is just the carryforward losses adjusted by expected tax rate plus a few miscellaneous credits etc?
Market Data 
Markets 
AI
